Table 2: Schizophrenic symptoms after ∆9-THC administration in humans
Subjects |
THC dose |
Schizophrenic symptoms |
Study |
Normal volunteers |
Δ9-THC (0.5 mg/kg, orally) |
Depersonalization, disconnected thoughts, paranoid ideas. |
[13] |
Healthy cannabis users
|
Δ9-THC (2.5, and 5 mg, i.v.) |
Positive symptoms: Suspiciousness, paranoid and grandiose delusions. Negative symptoms: Psychomotor retardation, and emotional withdrawal. |
[10] |
Subjects with paranoid ideation |
Δ9-THC (1.5 mg, i.v.) |
Paranoia Worry, anxiety, depression, and negative thoughts about the self. |
[51] |
Healthy subjects who were recent users of cannabis |
Δ9-THC milk decoction (16.5 mg) or synthetic Δ9-THC (dronabinol; 20 mg/kg) orally. |
Depersonalization, paranoid feelings, derealization and irrational anxiety.
|
[52] |
Healthy subjects who were cannabis users |
Δ9-THC (10 mg, orally) |
Psychotic symptoms Levels of anxiety |
[53]. |
Cannabis users |
Δ9-THC 8 mg or Δ9-THC 8 mg + CBD 16 mg (by inhalation through a vaporizer). |
BPRS negative symptoms Perceptual distortions and cognitive disorganization |
[57] |